SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as the community scrutinizes the revenue potential from the Super Bowl and the company's strategic push into prediction markets, amidst intense debate over regulatory challenges and competitive threats from alternative betting platforms.

WorldFinancial

WorldFinancial (WLFI) is trending amid a U.S. House probe into a significant investment deal, fueling polarized community discussion over its legitimacy as a Trump-linked project with ambitions in stablecoins and Real World Asset tokenization.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as investors await its upcoming earnings report and the highly anticipated, yet debated, POSCO partnership, with community sentiment split between expectations of a significant upside from strong HRC prices and the termination of a costly slab contract, versus concerns over recent equity dilution and historical underperformance within the steel sector.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as the community hotly debates the implications of the company's abrupt halt of its compounded weight-loss pill due to intense regulatory scrutiny, with bulls anticipating a short squeeze now that legal overhang is removed and bears expressing deep concern over management's decision-making and potential impact on growth.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is buzzing after hitting a $1 trillion market cap and joining the Nasdaq-100, with its strategic AI partnerships and expanding e-commerce driving a narrative of robust, tech-driven retail transformation that has the community actively discussing its surprising strength.

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Becton Dickinson & Co.

Becton, Dickinson And Co.

Becton Dickinson is trending as investors anticipate its Q1 earnings, with community discussions weighing expected declines against broad product demand and significant corporate actions like the pending Waters Corp. spin-off. Recent innovations in AI-driven flow cytometry, expanded biologics partnerships, and new medical device approvals are also driving conversation around the stock's current valuation and future growth.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

Recent news of SMX securing a $250 million Equity Line of Credit, extending its capital runway through 2028, is driving intense community discussion, with many anticipating a significant short squeeze and a potential repeat of the stock's historical parabolic surges.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending with community anticipation for its February BLA resubmission, as the FDA's request for the full HOPE-3 clinical study reportwithout needing new trialsreassures many about the regulatory path for its DMD therapy. Further excitement stems from expected updates on its StealthX exosome platform and recent significant institutional investment.

Confluent, Inc. engages in creating a data infrastructure platform focused on data in motion. The firm provides application architecture engagement, multi data center, security and upgrade engagement, and Amazon web services cloud deployment services. Its products include Confluent Cloud, Confluent Platform, WarpStream BYOC, Connectors, Flink, Stream Governance, and Confluent Hub. The company was founded by Edward Jay Kreps, Neha Narkhede, and Jun Rao on September 1, 2014, and is headquartered in Mountain View, CA.

Confluent Inc - Ordinary Shares Class A

Confluent Inc

Confluent Inc is trending following IBM's confirmed acquisition for $31 per share, underscoring the critical role of its real-time data streaming platform in accelerating AI and hybrid cloud strategies. The community is actively discussing the implications for the broader data infrastructure sector and debating the final share price as the deal progresses, with many perceiving the technology as significantly valuable.

SSgA Active Trust - State Street Consumer Discretionary Select Sector SPDR ETF

Consumer Discretionary Select Sector SPDR Fund

Consumer Discretionary (XLY) is a key battleground, with community discussion centered on a potential risk-on rebound following some positive retail data and rising consumer sentiment, despite persistent technical warnings like a death cross and a weakening discretionary-to-staples ratio. Heavyweight components like Amazon and Tesla continue to drive volatility with individual news, influencing whether the sector can overcome broader economic concerns and tariff impacts that point to a bifurcated consumer base.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DBV Technologies (NASDAQ:DBVT) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of DBV Technologies from a "sell" rating to a "hold" rating in a research report on Sunday...

DBV Technologies S.A. (NASDAQ:DBVT) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of DBV Technologies S.A. (NASDAQ:DBVT - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the ten brokerages that are presently covering the firm, MarketBeat...

DBV Technologies (NASDAQ:DBVT) Stock Price Passes Above 50 Day Moving Average - What's Next?

DBV Technologies (NASDAQ:DBVT) Share Price Passes Above 50-Day Moving Average - Should You Sell...

DBV Technologies (NASDAQ:DBVT) Downgraded to "Sell" Rating by Wall Street Zen

Wall Street Zen downgraded DBV Technologies from a "hold" rating to a "sell" rating in a research report on Saturday...

DBV Technologies (NASDAQ:DBVT) Shares Gap Up - Time to Buy?

DBV Technologies (NASDAQ:DBVT) Shares Gap Up - Still a Buy...

DBV Technologies (NASDAQ:DBVT) Shares Gap Up - Still a Buy?

DBV Technologies S.A. (NASDAQ:DBVT) Receives Average Rating of "Moderate Buy" from Brokerages

DBV Technologies S.A. (NASDAQ:DBVT - Get Free Report) has received a consensus rating of "Moderate Buy" from the ten brokerages that are currently covering the company, MarketBeat.com reports. Two...

DBV Technologies (NASDAQ:DBVT) Stock Price Down 9.1% - What's Next?

DBV Technologies (NASDAQ:DBVT) Shares Down 9.1% - Should You Sell...

DBV Technologies (NASDAQ:DBVT) Shares Up 3.1% - Should You Buy?

DBV Technologies (NASDAQ:DBVT) Trading 3.1% Higher - What's Next...

DBV Technologies (NASDAQ:DBVT) Stock Price Down 6.7% - Here's What Happened

DBV Technologies (NASDAQ:DBVT) Stock Price Down 6.7% - Here's Why...

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Chatillon, France.

DBV Technologies - ADR

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

DBVT
DBV Technologies

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DBVT News

DBVTDBV Technologies